Mosley Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Mosley Wealth Management's BMY Position: Q3 2026 in Review
Mosley Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 13% in Q3 2026, buying an estimated $27.1K and bringing the position to 3,800 shares worth $230K. The position accounts for 0.07% of the portfolio, ranked #155.
Mosley Wealth Management first reported a position in BMY in Q4 2023 and has held it in 6 quarters since. The position peaked at $337K in Q1 2024. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Mosley Wealth Management held 3,800 shares of Bristol-Myers Squibb worth $230K as of Q3 2026.
- Mosley Wealth Management bought 429 Bristol-Myers Squibb shares in Q3 2026, an estimated $27.1K.
- Bristol-Myers Squibb made up 0.07% of Mosley Wealth Management's portfolio in Q3 2026, its #155 holding.
- Mosley Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 6 quarters since.
- Mosley Wealth Management's Bristol-Myers Squibb position peaked at $337K in Q1 2024.
- 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Mosley Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.